XBIO Xenetic Biosciences Inc.

1.88
+0.25  (+15%)
Previous Close 1.63
Open 1.64
Price To Book 0.54
Market Cap 6,211,930
Shares 3,304,218
Volume 428,852
Short Ratio
Av. Daily Volume 302,753

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 enrolment closed in March 2019 due to slow enrolment.
XBIO-101
Endometrial cancer